TrialsgrambetaRCTs are beautiful

STICH

2016

Surgical Treatment for Ischemic Heart Failure — Extension Study (STICHES, 10-year follow-up)

In 1,212 patients with ischaemic cardiomyopathy (EF ≤ 35%) and CAD, coronary-artery bypass grafting plus medical therapy reduced 10-year all-cause mortality compared with medical therapy alone.

Result

Efficacy: All-cause mortalityHR 0.84 (95% CI 0.73-0.97) · P = 0.02

Below 1 favours coronary-artery bypass grafting plus medical therapy, above 1 favours medical therapy alone.

Event rates
Absolute difference
7.2 points
NNT
14

Absolute difference and NNT are derived from the event rates.

Also reported: At 10 years, CV death and death-or-CV-hospitalisation also reduced.

Original publication
Subtopic
CABG
Design
Open-label RCT with extended follow-up
Relevance
Important: one of several pillars.
Source
Velazquez EJ, et al. N Engl J Med. 2016;374(16):1511-1520.doi 10.1056/NEJMoa1602001

Discussion & critique

Original 5-year STICH result was neutral for the primary endpoint; significant survival benefit emerged only with 10-year follow-up, with substantial crossover between arms. Established a durable survival benefit of CABG in ischaemic cardiomyopathy.

Discussed in podcasts